The Opportunity exists for accredited investors to express interest to invest in a special purchase fund that will purchase up to twelve million units in Cordio Medical Limited.
Cordio Medical Ltd has created a Medical-grade system that converts an off the shelf mobile device into a medical device that allows the monitoring of medical conditions such as Congestive Heart Failure ("CHF") which afflicts 5.7 million Americans, through speech.
The Cordio HearOTM can sense fluid accumulation related to CHF through speech processing technologies and alert physicians prior to hospitalization providing a vital and potentially lifesaving warning. Capital raised will be used to support further clinical studies, Finance ongoing operations, develop US sales / business development strategy and team.
The companies website can be accessed here. Publications reviewing the effectiveness of the device can be accessed here and here
For further information please refer to the Investor flier in the Documents section. To access further information and be put in contact with the arranger, Register Interest.